BEIJING REAGENT LATEX PRODUCTS CO., LTD. – Trademark Portfolio

Entity Type: 99

BEIJING REAGENT LATEX PRODUCTS CO., LTD. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include SNOW LOTUS and REAGENT RUIJING. The owner is based in District, Beijing.

No.6 Xingguang Wujie,Opto Mechatronics

Industrial Park,Taihu Town,Tongzhou

District, Beijing 101100 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

BEIJING REAGENT LATEX PRODUCTS CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does BEIJING REAGENT LATEX PRODUCTS CO., LTD. have?

BEIJING REAGENT LATEX PRODUCTS CO., LTD. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does BEIJING REAGENT LATEX PRODUCTS CO., LTD. file in?

BEIJING REAGENT LATEX PRODUCTS CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are BEIJING REAGENT LATEX PRODUCTS CO., LTD.'s most well-known trademarks?

BEIJING REAGENT LATEX PRODUCTS CO., LTD.'s registered trademark portfolio includes well-known marks such as SNOW LOTUS and REAGENT RUIJING. These are among 3 currently registered trademarks in the portfolio.

What is BEIJING REAGENT LATEX PRODUCTS CO., LTD.'s trademark registration success rate?

BEIJING REAGENT LATEX PRODUCTS CO., LTD. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.